Sorry, you need to enable JavaScript to visit this website.

PREPIDIL® (dinoprostone) Principal Display Panel

PRINCIPAL DISPLAY PANEL - 3 g Syringe Applicator Label

NDC 0009-3359-01

Prepidil® Gel    0.5 mg*

dinoprostone cervical gel

For endocervical administration
Sterile
DOSAGE AND USE: See accompanying prescribing
information.
* Each 3 gram syringe applicator contains 0.5 mg
dinoprostone. Also contains 240 mg colloidal silicon
dioxide NF, 2760 mg triacetin USP.
Store in a refrigerator 2° to 8°C (36° to 46°F).

Distributed by
Pharmacia & Upjohn Co
Division of Pfizer Inc,
NY, NY 10017
LOT/EXP.:

Rx only
PAA056623

PRINCIPAL DISPLAY PANEL - 3 g Syringe Applicator Label

PRINCIPAL DISPLAY PANEL - 3 g Syringe Label

Prepidil® Gel    0.5 mg

dinoprostone cervical gel

Sterile
Store in a refrigerator 2° to 8°C (36° to 46°F).
One 3 gram syringe

Pfizer Injectables

Distributed by
Pharmacia & Upjohn Co
Division of Pfizer Inc, NY, NY 10017

NDC 0009-3359-01

PAA056625

PRINCIPAL DISPLAY PANEL - 3 g Syringe Label

PRINCIPAL DISPLAY PANEL - 3 gram Syringe Carton

Prepidil® Gel    0.5 mg*

dinoprostone cervical gel

For endocervical administration

Sterile
Package includes 2 shielded catheters - 10 mm tip and 20 mm tip

1–3 gram syringe

Pfizer Injectables

NDC 0009-3359-01

Rx only

PRINCIPAL DISPLAY PANEL - 3 gram Syringe Carton

PRINCIPAL DISPLAY PANEL - 3 g Syringe Bundle Label

NDC 0009-3359-02
Contains 5 of NDC 0009-3359-01

Prepidil® Gel    0.5 mg

dinoprostone cervical gel

5–3 gram syringes

Distributed by
Pharmacia & Upjohn Co
Division of Pfizer Inc, NY, NY 10017

Rx only

PAA056624

PRINCIPAL DISPLAY PANEL - 3 g Syringe Bundle Label

What's New

No Current Announcements.

Contact Pfizer Medical

Report an Adverse Event
1-800-438-1985

Search

Please enter your search term(s) for PREPIDIL®